ARCHIVES

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Prevention Trials Should Get More Funding, Coltman Says.

May 18, 2001

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005